| Business Name: |
Idenix Pharmaceuticals Inc |
| Address: |
60 Hampshire St, Cambridge, Massachusetts 02139 |
| Phone Number: |
(617) 876-5883 |
| Website Address: |
idenix.com |
| Annual Revenue (USD): |
Unknown |
| Location Type: |
Branch |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B & B2C |
| Business Category: |
|
| SIC Code: |
2834 |
| NAICS Code: |
325412 |
| Share This Business: |
|
| Related Businesses: |
Infinity Pharmaceuticals Inc - Cambridge, MA 02139
Novartis Corporation - Cambridge, MA 02139
Millennium Pharmaceuticals - Cambridge, MA 02139
Cerulean Pharma Inc - Cambridge, MA 02139
Kedrion Biopharma Inc - Cambridge, MA 02139
R A Pharmaceuticals - Cambridge, MA 02139
Johnson & Johnson - Cambridge, MA 02139
Alnara Pharmaceuticals Inc - Cambridge, MA 02139
Agios Pharmaceuticals Inc - Cambridge, MA 02139
Novartis Vaccines & Dgnstcs - Cambridge, MA 02139
Sirtris Pharmaceuticals Inc - Cambridge, MA 02139
Novartis Vaccines And Diagnostics Inc - Cambridge, MA 02139
Intellikine LLC - Cambridge, MA 02139
Genzyme Corporation - Cambridge, MA 02139
Genpath Pharmaceuticals Inc - Cambridge, MA 02139
Aveo Pharmaceuticals Inc - Cambridge, MA 02139
Novirio Pharmaceuticals Inc - Cambridge, MA 02139
Idm Pharma Inc - Cambridge, MA 02139
Tbk Pharmaceuticals Inc - Cambridge, MA 02139
Vertex Pharmaceuticals Inc - Cambridge, MA 02139
|
The company Idenix Pharmaceuticals Inc provides BOTH services in the form of from its branch in Massachusetts.
1 to 4 employees work for Idenix Pharmaceuticals Inc, and the business now earns Unknown per annum.
Idenix Pharmaceuticals Inc was launched in 0 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 .
To contact Idenix Pharmaceuticals Inc, please call with the phone number (617) 876-5883 or visit its branch at 60 Hampshire St in Cambridge, Massachusetts 02139.
The location of the branch can also be found using the coordinates .
Read more details about this business on the webpage idenix.com or follow the company’s social media accounts, on Twitter and on Facebook.